Genpact LTD G
Genpact is an agentic and advanced technology solutions company recognized for its deep industry knowledge, process intelligence and last mile expertise. With decades of client trust and a strong partner ecosystem, we provide innovative solutions that transform how businesses run. Powered by a team with an active learning mindset and client centricity at its core, we deliver lasting value for the world's leading enterprises.
We have over 146,500 employees and serve clients from more than 35 countries around the world. Our 2025 total net revenues were $5.1 billion.
Genpact was established more than 25 years ago as the global capability center for the General Electric Company ("GE"). Our mandate was to perfect a set of shared business processes using Lean Six Sigma and other rigorous methodologies. The work was highly detailed and operationally complex, establishing Genpact as one of the world's leading business process experts. This operational discipline, combined with our end-to-end process view, granular data benchmarking capabilities, and operator-led approach has shaped our culture and core competencies in process design, data management, and industry domain knowledge. We believe this foundational process intelligence positions us to deliver differentiated AI and agentic solutions that address the operational complexities and "last mile" execution challenges our clients are facing.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.08B | $4.77B | $4.48B | $4.37B | $4.02B | $3.71B | $3.52B | $3.00B | $2.74B | $2.57B |
| Cost of revenue | $3.25B | $3.08B | $2.91B | $2.83B | $2.59B | $2.42B | $2.29B | $1.92B | $1.68B | $1.55B |
| Gross profit | $1.83B | $1.69B | $1.57B | $1.54B | $1.43B | $1.29B | $1.23B | $1.08B | $1.06B | $1.02B |
| SG&A | $1.05B | $967.1M | $913.1M | $938.4M | $865.7M | $789.8M | $794.9M | $693.9M | $689.5M | $653.0M |
| Operating income | $750.2M | $702.1M | $630.9M | $502.2M | $509.0M | $438.7M | $429.4M | $348.2M | $331.3M | $341.2M |
| Interest expense | — | $79.5M | $66.3M | $58.1M | — | — | — | — | — | — |
| Pre-tax income | $730.1M | $676.8M | $602.2M | $465.2M | $483.1M | $400.5M | $399.4M | $362.0M | $320.6M | $329.6M |
| Income tax | $177.7M | $163.2M | $29.0M | $111.8M | $113.7M | $92.2M | $94.5M | $80.8M | $59.7M | $62.1M |
| Net income | $552.5M | $513.7M | $631.3M | $353.4M | $369.4M | $308.3M | $304.9M | $282.0M | $263.1M | $269.7M |
| EPS, basic | 3.18 | 2.88 | 3.46 | 1.92 | 1.97 | 1.62 | 1.60 | 1.48 | 1.36 | 1.30 |
| EPS, diluted | 3.13 | 2.85 | 3.41 | 1.88 | 1.91 | 1.57 | 1.56 | 1.45 | 1.34 | 1.28 |
| Shares, diluted (wtd. avg.) | $176.6M | $180.4M | $185.1M | $188.1M | $193.0M | $195.8M | $195.2M | $194.0M | $197.0M | $210.1M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $853.8M | $648.2M | $583.7M | $646.8M | $899.5M | $680.4M | $467.1M | $368.4M | $504.5M | $422.6M |
| Short-term investments | $350.0M | $23.4M | $0 | — | — | — | — | — | — | — |
| Receivables | $1.24B | $1.20B | $1.12B | $994.8M | $887.7M | $881.0M | $914.3M | $774.2M | $693.1M | $615.3M |
| Total current assets | $2.66B | $2.08B | $1.89B | $1.78B | $1.92B | $1.75B | $1.55B | $1.36B | $1.43B | $1.23B |
| Property, plant and equipment | $190.4M | $207.9M | $189.8M | $180.8M | $215.1M | $231.1M | $254.0M | $212.7M | $207.0M | $193.2M |
| Goodwill | $1.78B | $1.67B | $1.68B | $1.68B | $1.73B | $1.70B | $1.57B | $1.39B | $1.34B | $1.07B |
| Other intangibles | $67.0M | $26.9M | $53.0M | $89.7M | $169.6M | $236.7M | $230.9M | $177.1M | $131.6M | $78.9M |
| Total assets | $5.84B | $4.99B | $4.81B | $4.59B | $4.98B | $4.87B | $4.45B | $3.53B | $3.45B | $2.89B |
| Accounts payable | $27.5M | $36.5M | $27.7M | $35.8M | $25.0M | $13.9M | $22.0M | $42.6M | $15.1M | $9.8M |
| Short-term debt | $376.0M | $26.2M | $432.2M | $26.1M | $383.4M | $33.5M | $33.5M | $33.5M | $39.2M | $39.2M |
| Total current liabilities | $1.60B | $963.7M | $1.32B | $1.10B | $1.31B | $1.20B | $910.2M | $976.3M | $838.8M | $731.4M |
| Long-term debt | $1.17B | $1.20B | $824.7M | $1.25B | $1.27B | $1.31B | $1.34B | $975.6M | $1.01B | $698.2M |
| Total liabilities | $3.29B | $2.60B | $2.56B | $2.76B | $3.08B | $3.04B | $2.77B | $2.13B | $2.02B | $1.59B |
| Retained earnings | $1.39B | $1.24B | $1.09B | $780.0M | $732.5M | $741.7M | $648.7M | $438.5M | $356.0M | $358.1M |
| Total equity | $2.55B | $2.39B | $2.25B | $1.83B | $1.90B | $1.83B | $1.69B | $1.40B | $1.42B | $1.29B |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $812.9M | $615.4M | $490.8M | $443.7M | $694.3M | $584.3M | $427.9M | $339.5M | $359.1M | $345.8M |
| Depreciation and amortisation | $70.7M | $69.8M | $72.5M | $86.8M | $109.1M | $116.5M | $96.1M | $64.9M | $58.5M | $54.6M |
| Stock-based compensation | $89.6M | $66.4M | $88.6M | $77.4M | $82.0M | $74.0M | $83.9M | $49.0M | $35.7M | $25.1M |
| Capital expenditure | $78.2M | $82.8M | $55.4M | $50.6M | $53.3M | $70.2M | $74.9M | $85.0M | $57.2M | $81.9M |
| Investing cash flow | -$495.5M | -$106.0M | -$78.9M | -$36.6M | -$122.7M | -$266.4M | -$357.1M | -$276.1M | -$362.0M | -$125.8M |
| Financing cash flow | -$106.8M | -$424.8M | -$483.0M | -$571.4M | -$332.9M | -$92.0M | $39.6M | -$135.2M | $47.2M | -$232.8M |
| Dividends paid | $117.7M | $108.5M | $100.0M | $91.8M | $80.5M | $74.2M | $64.7M | $57.1M | $46.7M | — |
| Buybacks | — | $252.7M | $225.5M | $214.1M | $298.2M | $137.1M | $30.0M | $154.2M | $219.8M | $345.2M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001398659-26-000004.
Others in SIC 8742
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| BAH | Booz Allen Hamilton Holding Corp | $8.76B | 10.6x | -6.4% |
| FCN | FTI CONSULTING, INC | $4.19B | 18.4x | 2.4% |
| EXPO | EXPONENT INC | $3.25B | 33.0x | 4.2% |
| HURN | Huron Consulting Group Inc. | $2.52B | 26.6x | 11.9% |
| ASTH | Astrana Health, Inc. | $2.14B | 83.6x | 56.4% |
| ICFI | ICF International, Inc. | $1.58B | 17.8x | -7.3% |
| BWMN | Bowman Consulting Group Ltd. | $735.5M | 58.1x | 14.9% |
| ONT | Onterris, Inc. | $626.8M | — | 19.3% |